Transcript - Yaz, Yasmin, Ocella, Gianvi - Birth Control Drugs Settlement
Bayer Pharmaceuticals, manufacturer of the birth control drugs Yaz and Yasmin and their generic versions Ocella and Gianvi, marketed by Teva Pharmaceuticals, agreed to settle over 8,250 claims for $1.7 billion. Launched in 2001, Yaz and Yasmin were the first brands of birth control pills to utilize a type of synthetic hormone to suppress ovulation in women and prevent pregnancy.
Multiple studies show a dramatic increase of having a heart attack, stroke, developing blood clots, deep vein thrombosis, or suffering a pulmonary embolism if you have taken these birth control pills. Other claims allege gallbladder injuries. In 2008, the FDA announced that between 2004 and 2008, more than 50 deaths had been reported allegedly caused by these pills. And the FDA's own study found a 74% increased risk of blood clots among those taking these pills. Due to Bayer Pharmaceutical's aggressive advertising, Yaz, especially, has become one of the most popularly prescribed birth control pills in the country. Millions of women around the world have taken these pills, and there are currently over 3,000 pending lawsuits alleging that patients were not told of the severe and deadly side effects.
Our goal at Moll Law Group is to inform consumers of potentially dangerous products and provide assistance with the filing of claims. If you have a case and would like a prompt and confidential evaluation, please fill out our free consultation form. For free consumer safety information and case updates, visit us at legalnewsnetwork.com